KPRX
Price
$2.78
Change
-$0.00 (-0.00%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
9.55M
PRME
Price
$3.24
Change
-$0.20 (-5.81%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
577.61M
63 days until earnings call
Interact to see
Advertisement

KPRX vs PRME

Header iconKPRX vs PRME Comparison
Open Charts KPRX vs PRMEBanner chart's image
Kiora Pharmaceuticals
Price$2.78
Change-$0.00 (-0.00%)
Volume$104
Capitalization9.55M
Prime Medicine
Price$3.24
Change-$0.20 (-5.81%)
Volume$37.04K
Capitalization577.61M
KPRX vs PRME Comparison Chart in %
Loading...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPRX vs. PRME commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPRX is a Buy and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (KPRX: $2.78 vs. PRME: $3.44)
Brand notoriety: KPRX and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPRX: 30% vs. PRME: 44%
Market capitalization -- KPRX: $9.55M vs. PRME: $577.61M
KPRX [@Biotechnology] is valued at $9.55M. PRME’s [@Biotechnology] market capitalization is $577.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPRX’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • KPRX’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than KPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPRX’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 2 bullish TA indicator(s).

  • KPRX’s TA Score: 4 bullish, 5 bearish.
  • PRME’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, KPRX is a better buy in the short-term than PRME.

Price Growth

KPRX (@Biotechnology) experienced а +6.11% price change this week, while PRME (@Biotechnology) price change was +6.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

PRME is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($578M) has a higher market cap than KPRX($9.55M). PRME YTD gains are higher at: 17.808 vs. KPRX (-15.758). KPRX has higher annual earnings (EBITDA): -9.41M vs. PRME (-197.38M). PRME has more cash in the bank: 102M vs. KPRX (20.7M). KPRX has less debt than PRME: KPRX (430K) vs PRME (120M). PRME has higher revenues than KPRX: PRME (4.96M) vs KPRX (0).
KPRXPRMEKPRX / PRME
Capitalization9.55M578M2%
EBITDA-9.41M-197.38M5%
Gain YTD-15.75817.808-88%
P/E Ratio3.67N/A-
Revenue04.96M-
Total Cash20.7M102M20%
Total Debt430K120M0%
FUNDAMENTALS RATINGS
KPRX vs PRME: Fundamental Ratings
KPRX
PRME
OUTLOOK RATING
1..100
1656
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7737
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (20) in the Pharmaceuticals Other industry is somewhat better than the same rating for PRME (64) in the null industry. This means that KPRX’s stock grew somewhat faster than PRME’s over the last 12 months.

KPRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as PRME (100) in the null industry. This means that KPRX’s stock grew similarly to PRME’s over the last 12 months.

KPRX's SMR Rating (100) in the Pharmaceuticals Other industry is in the same range as PRME (100) in the null industry. This means that KPRX’s stock grew similarly to PRME’s over the last 12 months.

PRME's Price Growth Rating (37) in the null industry is somewhat better than the same rating for KPRX (77) in the Pharmaceuticals Other industry. This means that PRME’s stock grew somewhat faster than KPRX’s over the last 12 months.

PRME's P/E Growth Rating (100) in the null industry is in the same range as KPRX (100) in the Pharmaceuticals Other industry. This means that PRME’s stock grew similarly to KPRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPRXPRME
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 26 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUGP6.730.71
+11.79%
SU Group Holdings Limited
FBK53.920.24
+0.45%
FB Financial Corp
UNB26.10-0.20
-0.76%
Union Bankshares
LII559.48-7.52
-1.33%
Lennox International
MGPI29.35-0.42
-1.41%
MGP Ingredients

KPRX and

Correlation & Price change

A.I.dvisor tells us that KPRX and SYRE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KPRX and SYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
-2.80%
SYRE - KPRX
33%
Poorly correlated
-2.45%
PRME - KPRX
32%
Poorly correlated
+0.29%
CGEN - KPRX
31%
Poorly correlated
-4.76%
ABVX - KPRX
31%
Poorly correlated
+2.78%
RCUS - KPRX
31%
Poorly correlated
+0.47%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+0.29%
CRSP - PRME
58%
Loosely correlated
-0.90%
BEAM - PRME
54%
Loosely correlated
-0.06%
RXRX - PRME
54%
Loosely correlated
-0.51%
CRBU - PRME
48%
Loosely correlated
-2.02%
ABCL - PRME
47%
Loosely correlated
-1.15%
More